Literature DB >> 23657171

Physical activity and lower limb lymphedema among uterine cancer survivors.

Justin C Brown1, Gabriella M John, Saya Segal, Christina S Chu, Kathryn H Schmitz.   

Abstract

PURPOSE: Physical activity (PA) is known to provide physical and mental health benefits to uterine cancer survivors. However, it is unknown if PA is associated with lower limb lymphedema (LLL), an accumulation of protein-rich fluid in the lower limbs. Therefore, we sought to examine the association between PA and LLL in uterine cancer survivors, with a focus on walking.
METHODS: We conducted a cross-sectional study using mailed surveys among uterine cancer survivors who received care at a university-based cancer center. We asked about PA, walking, and LLL symptoms using validated self-report questionnaires. PA was calculated using MET-hours per week, and walking was calculated using blocks per day.
RESULTS: The response rate to our survey was 43%. Among the 213 uterine cancer survivors in our survey, 36% were classified as having LLL. Compared with participants who reported <3 MET · h · wk of PA, participants who reported ≥ 18.0 MET · h · wk of PA had an odds ratio of LLL of 0.32 (95% confidence interval, 0.15-0.69; P trend = 0.003). Stratified analyses suggested the association between PA and LLL existed only among women with body mass index (BMI) <30 kg · m (P trend = 0.007) compared with women with BMI ≥ 30 kg · m (P trend = 0.47). Compared with participants who reported <4.0 blocks per day of walking, participants who reported ≥ 12 blocks per day of walking had an odds ratio of LLL of 0.19 (95% confidence interval, 0.09-0.43; P trend < 0.0001). Stratified analyses suggested the association between walking and LLL was similar among women with BMI <30 kg · m (P trend = 0.007) and women with BMI ≥ 30 kg · m (P trend = 0.03).
CONCLUSION: Participation in higher levels of PA or walking is associated with reduced proportions of LLL in dose-response fashion. These findings should be interpreted as preliminary and should be investigated in future studies.

Entities:  

Mesh:

Year:  2013        PMID: 23657171      PMCID: PMC4122421          DOI: 10.1249/MSS.0b013e318299afd4

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  46 in total

1.  Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study.

Authors:  H Q Huang; M F Brady; D Cella; G Fleming
Journal:  Int J Gynecol Cancer       Date:  2007 Mar-Apr       Impact factor: 3.437

2.  A pilot study using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors.

Authors:  Jeanne Carter; Leigh Raviv; Kathleen Appollo; Raymond E Baser; Alexia Iasonos; Richard R Barakat
Journal:  Gynecol Oncol       Date:  2010-02-16       Impact factor: 5.482

3.  Physical Activity and Lymphedema (the PAL trial): assessing the safety of progressive strength training in breast cancer survivors.

Authors:  Kathryn H Schmitz; Andrea B Troxel; Andrea Cheville; Lorita L Grant; Cathy J Bryan; Cynthia R Gross; Leslie A Lytle; Rehana L Ahmed
Journal:  Contemp Clin Trials       Date:  2009-01-08       Impact factor: 2.226

4.  Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial.

Authors:  Mary M McDermott; Philip Ades; Jack M Guralnik; Alan Dyer; Luigi Ferrucci; Kiang Liu; Miriam Nelson; Donald Lloyd-Jones; Linda Van Horn; Daniel Garside; Melina Kibbe; Kathryn Domanchuk; James H Stein; Yihua Liao; Huimin Tao; David Green; William H Pearce; Joseph R Schneider; David McPherson; Susan T Laing; Walter J McCarthy; Adhir Shroff; Michael H Criqui
Journal:  JAMA       Date:  2009-01-14       Impact factor: 56.272

5.  Physical activity in the United States measured by accelerometer.

Authors:  Richard P Troiano; David Berrigan; Kevin W Dodd; Louise C Mâsse; Timothy Tilert; Margaret McDowell
Journal:  Med Sci Sports Exerc       Date:  2008-01       Impact factor: 5.411

Review 6.  Lymphedema in gynecologic cancer survivors: an area for exploration?

Authors:  Suzy Lockwood-Rayermann
Journal:  Cancer Nurs       Date:  2007 Jul-Aug       Impact factor: 2.592

7.  Weight lifting in women with breast-cancer-related lymphedema.

Authors:  Kathryn H Schmitz; Rehana L Ahmed; Andrea Troxel; Andrea Cheville; Rebecca Smith; Lorita Lewis-Grant; Cathy J Bryan; Catherine T Williams-Smith; Quincy P Greene
Journal:  N Engl J Med       Date:  2009-08-13       Impact factor: 91.245

8.  Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis.

Authors:  Andrew J Spillane; Robyn P M Saw; Monica Tucker; Karen Byth; John F Thompson
Journal:  Ann Surg       Date:  2008-08       Impact factor: 12.969

9.  Treatment for upper-limb and lower-limb lymphedema by professionals specializing in lymphedema care.

Authors:  D Langbecker; S C Hayes; B Newman; M Janda
Journal:  Eur J Cancer Care (Engl)       Date:  2008-09-03       Impact factor: 2.520

10.  Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma.

Authors:  Harue Tada; Satoshi Teramukai; Masanori Fukushima; Hiroshi Sasaki
Journal:  BMC Cancer       Date:  2009-02-05       Impact factor: 4.430

View more
  8 in total

1.  Physical activity, daily walking, and lower limb lymphedema associate with physical function among uterine cancer survivors.

Authors:  Justin C Brown; Lilie L Lin; Saya Segal; Christina S Chu; Ashley E Haggerty; Emily M Ko; Kathryn H Schmitz
Journal:  Support Care Cancer       Date:  2014-06-07       Impact factor: 3.603

2.  Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Crystal S Denlinger; Tara Sanft; K Scott Baker; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Robin M Lally; Terry S Langbaum; Allison L McDonough; Michelle Melisko; Jose G Montoya; Kathi Mooney; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; William Pirl; M Alma Rodriguez; Kathryn J Ruddy; Paula Silverman; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2018-10       Impact factor: 11.908

Review 3.  Recent progress in the treatment and prevention of cancer-related lymphedema.

Authors:  Simona F Shaitelman; Kate D Cromwell; John C Rasmussen; Nicole L Stout; Jane M Armer; Bonnie B Lasinski; Janice N Cormier
Journal:  CA Cancer J Clin       Date:  2014-11-19       Impact factor: 508.702

4.  The frequency and persistence of lymphedema diagnosis and self-reported symptoms over 5 years in patients with endometrial carcinoma.

Authors:  Julia Ritchie; Quetrell Heyward; Nicholas Taylor; Emily Ko; Ashley F Haggerty; Ashley Graul
Journal:  Gynecol Oncol Rep       Date:  2022-05-07

5.  Survivorship: healthy lifestyles, version 2.2014.

Authors:  Crystal S Denlinger; Jennifer A Ligibel; Madhuri Are; K Scott Baker; Wendy Demark-Wahnefried; Don Dizon; Debra L Friedman; Mindy Goldman; Lee Jones; Allison King; Grace H Ku; Elizabeth Kvale; Terry S Langbaum; Kristin Leonardi-Warren; Mary S McCabe; Michelle Melisko; Jose G Montoya; Kathi Mooney; Mary Ann Morgan; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; Muhammad Raza; M Alma Rodriguez; Karen L Syrjala; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2014-09       Impact factor: 11.908

6.  Feasibility of a Pilot Randomized Controlled Trial Examining a Multidimensional Intervention in Women with Gynecological Cancer at Risk of Lymphedema.

Authors:  Shirin M Shallwani; Anna Towers; Anne Newman; Shannon Salvador; Angela Yung; Lucy Gilbert; Walter H Gotlieb; Xing Zeng; Doneal Thomas
Journal:  Curr Oncol       Date:  2021-01-13       Impact factor: 3.677

7.  ACCEPTANCE: protocol for a feasibility study of a multicomponent physical activity intervention following treatment for cervical cancer.

Authors:  Nessa Millet; Hilary J McDermott; Fehmidah Munir; Charlotte L Edwardson; Esther L Moss
Journal:  BMJ Open       Date:  2022-01-03       Impact factor: 2.692

8.  Association between Body Mass Index and Physical Function among Endometrial Cancer Survivors.

Authors:  Xiaochen Zhang; Justin C Brown; Kathryn H Schmitz
Journal:  PLoS One       Date:  2016-08-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.